Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Cardinal Health, Inc (NYSE: CAH) closed the day trading at $196.79 up 0.74% from the previous closing price of $195.34. In other words, the price has increased by $0.74 from its previous closing price. On the day, 2.61 million shares were traded. CAH stock price reached its highest trading level at $200.14 during the session, while it also had its lowest trading level at $194.15.
Ratios:
For a better understanding of CAH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.50. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 0.96.
On February 05, 2025, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $140 to $150.
TD Cowen Upgraded its Hold to Buy on January 08, 2025, whereas the target price for the stock was revised from $130 to $144.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 20 ’25 when WEITZMAN DEBORAH bought 21,367 shares for $150.53 per share.
WEITZMAN DEBORAH sold 21,367 shares of CAH for $3,216,375 on Aug 20 ’25. The CEO, PSS Segment now owns 53,428 shares after completing the transaction at $150.53 per share. On Aug 20 ’25, another insider, Hollar Jason M., who serves as the Chief Executive Officer of the company, sold 35,901 shares for $150.04 each. As a result, the insider received 5,386,566 and left with 200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAH now has a Market Capitalization of 46756327424 and an Enterprise Value of 51343327232. As of this moment, Cardinal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.71, and their Forward P/E ratio for the next fiscal year is 17.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.01. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20. Its current Enterprise Value per Revenue stands at 0.219 whereas that against EBITDA is 14.487.
Stock Price History:
The Beta on a monthly basis for CAH is 0.64, which has changed by 0.65234303 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, CAH has reached a high of $197.67, while it has fallen to a 52-week low of $110.63. The 50-Day Moving Average of the stock is 24.57%, while the 200-Day Moving Average is calculated to be 33.23%.
Shares Statistics:
Over the past 3-months, CAH traded about 2.53M shares per day on average, while over the past 10 days, CAH traded about 2983090 shares per day. A total of 238.00M shares are outstanding, with a floating share count of 236.96M. Insiders hold about 0.27% of the company’s shares, while institutions hold 88.64% stake in the company. Shares short for CAH as of 1760486400 were 6612284 with a Short Ratio of 2.61, compared to 1757894400 on 7083094. Therefore, it implies a Short% of Shares Outstanding of 6612284 and a Short% of Float of 3.2.
Dividends & Splits
CAH’s forward annual dividend rate is 2.03, up from 2.033 a year ago. Against a Trailing Annual Dividend Yield of 0.010407494. The stock’s 5-year Average Dividend Yield is 2.54. The current Payout Ratio is 31.43% for CAH, which recently paid a dividend on 2025-10-01 with an ex-dividend date of 2026-01-02. Stock splits for the company last occurred on 2001-04-23 when the company split stock in a 3:2 ratio.
Earnings Estimates
Cardinal Health, Inc (CAH) is currently under the scrutiny of 12.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $2.68, with high estimates of $2.9 and low estimates of $2.52.
Analysts are recommending an EPS of between $10.08 and $9.74 for the fiscal current year, implying an average EPS of $9.82. EPS for the following year is $11.05, with 15.0 analysts recommending between $11.33 and $10.67.
Revenue Estimates
12 analysts predict $64.77B in revenue for. The current quarter. It ranges from a high estimate of $66.24B to a low estimate of $63.97B. As of. The current estimate, Cardinal Health, Inc’s year-ago sales were $55.26BFor the next quarter, 12 analysts are estimating revenue of $62.75B. There is a high estimate of $64.49B for the next quarter, whereas the lowest estimate is $60.67B.
A total of 13 analysts have provided revenue estimates for CAH’s current fiscal year. The highest revenue estimate was $261.31B, while the lowest revenue estimate was $255.37B, resulting in an average revenue estimate of $258.28B. In the same quarter a year ago, actual revenue was $222.58BBased on 14 analysts’ estimates, the company’s revenue will be $279.4B in the next fiscal year. The high estimate is $290B and the low estimate is $265.47B.
